That is very important, due to the fact that the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (jeff brown). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're developed to do. This was an advancement practically no one observed. However it's going to have extensive implications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be lots of investment chances in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it drew back perhaps significantly before going higher - jeff brown market predictions. I've been covering bitcoin for a long period of time now. Among the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly informing readers. But that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff brown top stock pick 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many great personal business on the verge of striking the general public markets And I've been dealing with a brand-new method for you to invest even before these business go public.
This chance has actually been developing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to reserve your area free of charge.
Emma Walsh here, managing editor of the Journal. Regular Journal readers know that tech isn't our usual beat (genetic sequencing companies jeff brown). And when it pertains to tech investing, we leave it to the specialists. Fortunately, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing experts we understand (future report review). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big image and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing exponential growth and creating unbelievable chances for investors. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. bleeding edge. However regardless of what many readers might believe, this is a pattern that's just starting. Even though the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (last week). Losing 2 months of manufacturing and sales actually affects the number of 5G devices are offered in the fiscal year. When you consider all of that, selling 250 million systems is amazing. More importantly, the hold-ups triggered by the pandemic produced a heap of suppressed need. Which demand is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G devices will be delivered in 2021 - jeff brown 1 biotech. Which's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its 3 different stages.
In Phase 2, 5G devices go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services begin to be offered (the legacy report prediction). That's when we begin to see applications operating on 5G networks. Think about things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase 3 by this summer. This begins something of a virtuous cycle: The majority of individuals do not actually appreciate the innovation. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open up a suite of amazing applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these technologies need 5G. The financial investment chances going forward will be enormous. Stepping away from 5G, the next essential innovation I predict in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR uses a similar idea but with our hereditary code. "Typos" in our genome can lead to illness. CRISPR can correct these "typos." For many years, CRISPR was mostly a niche technology that wasn't well understood. And during that time, there were truly only three companies operating in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire market is successfully a greenfield opportunity.
There's room for many companies to exist in this space. exponential growth. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things taking place at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its latest Alpha, Fold software can properly anticipate the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is necessary because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has actually been a trial-and-error procedure. Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're designed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug therapies produced utilizing this innovation. This was among those breakthroughs that practically no one discovered. However it's going to have profound implications for treating disease. And, obviously, there will be lots of investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it pulled back maybe considerably before going higher. I've been covering bitcoin for a long period of time now. One of the very first research reports I ever published was on bitcoin - self-driving cars. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. tech predictions. Mass, Mutual is a 150-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus offer prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the details is up to date since February 2021, but we might not individually verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to choose winning innovation stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an excellent point of view on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares much of his finest choices in the Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully forecasted a few of the biggest financial occasions of the past 20 years. Although he does not appear to launch his choices to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it right whenever, but Jeff Brown's precise predictions have made him legions of dedicated fans. That states a lot about his ability. The Future Report is released by Brownstone Research study, a popular financial research study publisher. Brownstone Research study uses several research study services with a variety of expertises - black sea.
The business is also associated with Bonner & Partners, another well-respected research study publisher - future report review. On its site, Brownstone says its mission is to provide retail investors with professional-grade research study: "For too long, the finest investment research has not been available to individual financiers. It has actually been normally booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. united states. The objective of Brownstone Research is to make that type of proprietary research study readily available to any financiers seeking to get an edge in the marketplaces. The objective is basic to deliver special and profitable investment research study found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you know even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. tech stocks. Whatever he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown thinks S.A.V. jeff brown genome sequencing stock. could be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 advanced technologies: expert system and electrical cars and trucks. Musk hopes the combination will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the automobile market's Holy Grail. As you know, electric lorries and self-driving vehicle stocks have been substantial this year, but the Wall Street maker has actually approved hype without much tangible result. Despite an extreme increase in competitors over the previous couple of years, Brown still believes Musk has the very best chance of putting everything together.
tech might be the magic string that connects everything together. S.A.V. means Shared Autonomous Vehicle, and it could be the future of transportation. Basically, this technology would permit you to rent your car as a self-governing, self-driving taxi when you're not using it. You just leave the car and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a substantial chunk of the revenues. It sounds crazy, however it could be closed than you think.